This strongly suggests that some degree of feedback compensation is occurring over time, a finding that has been supported by a recent study that actively targeted this feedback loop using dietary and pharmacological strategies to improve the efficacy of PI3K inhibition in the treatment of tumor-bearing mice [87]. The gene discussed is PIK3CB; the disease is neoplasm.